Does Chronic Immune Thrombocytopenia Lead to Hearing Loss?

نویسندگان

چکیده

Objective: We aimed to investigate the incidence of hearing loss in patients followed up for Chronic Immune Thrombocytopenia Purpura (ITP). Material and Methods: All over age 18 who referred hematology outpatient clinic between January June 2020 with diagnosis ITP were included study. Hearing tests diagnosed received first-line treatment (IVIG corticosteroid) any reason other than ear diseases during their evaluated retrospectively. Patients a history loss, perforation tympanic membrane or had squeal due previous chronic infection operation excluded from In addition, patients' age, gender, time diagnosis, platelet values at audiological evaluation, concomitant disease, splenectomy, additional drug use ISTH-SSC Bleeding Evaluation Score data also recorded. Results: Of 34 cases, 58.8% (n=20) female 41.2% (n=14) male. The mean was 49.06±18.26. Similarly, when compared, usage IVIG/Methylprednisolone, IVIG/ Methylprednisolone /Eltrombopag, IVIG/Methylprednisolone /Rituximab/Eltrombopag not found be factor that would cause (p>0.05). No statistical correlation (months) Conclusion: Parameters such as various drugs used course presence disease do loss.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Point:Counterpoint: Chronic hypoxia-induced pulmonary hypertension does/does not lead to loss of pulmonary vasculature POINT: CHRONIC HYPOXIA-INDUCED PULMONARY HYPERTENSION DOES LEAD TO LOSS OF PULMONARY VASCULATURE

This debate focuses on whether, and to what extent, loss of small precapillary arteries is associated with the elevation in pulmonary artery pressure and resistance that accompanies chronic hypoxia-induced pulmonary hypertension. The issue has become the focus of much debate for a number of reasons. Papers from McLoughlin and his group (5, 6) have provided conclusive evidence that there is cons...

متن کامل

Sunitinib Induced Immune Thrombocytopenia

Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems including hematologic system. Although the neutropenia and thrombocytopenia commonly happens as Gra...

متن کامل

Sunitinib Induced Immune Thrombocytopenia

Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems including hematologic system. Although the neutropenia and thrombocytopenia commonly happens as Gra...

متن کامل

Infectious causes of chronic immune thrombocytopenia.

Persistent thrombocytopenia may be the consequence of chronic infections with hepatitis C virus (HCV), human immunodeficiency virus (HIV), and Helicobacter pylori, and should be considered in the differential diagnosis of primary immune thrombocytopenia (ITP). Studies have shown that on diagnosis of infections, treatment of the primary disease often results in substantial improvement or complet...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Medical Science and Discovery

سال: 2022

ISSN: ['2148-6832']

DOI: https://doi.org/10.36472/msd.v9i10.819